Icomb

Ramipril and Amlodipine besilate, the active ingredients in Icomb, are an ACE inhibitor and a calcium‑channel blocker presented as oral tablets for systemic use. They treat hypertension in adult patients by lowering elevated blood pressure and reducing cardiovascular risk. GNH USA supplies Icomb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Icomb is an antihypertensive combination that acts on the renin‑angiotensin system and vascular smooth‑muscle tone. - Essential hypertension: provides sustained blood‑pressure reduction in patients with primary high blood pressure. - Secondary hypertension: assists in controlling pressure that results from identifiable causes such as renal disease. - Hypertensive heart disease: helps lower after‑load and limits cardiac remodeling associated with long‑term hypertension.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after standing. - Peripheral edema: swelling of ankles or feet. - Headache: mild to moderate intensity. - Flushing: transient warmth and redness. - Fatigue: general feeling of tiredness.

Serious or Rare Side Effects: - Angioedema: rapid swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure causing faintness. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Myocardial infarction: chest pain indicative of heart attack. - Renal impairment: sudden decrease in kidney function. - Hyperkalemia: elevated blood potassium levels.

Before initiating therapy, consider the following precautions. - Blood pressure monitoring: check baseline and periodic readings to assess efficacy. - Renal function assessment: evaluate serum creatinine and eGFR, especially in patients with kidney disease. - Electrolyte review: monitor potassium and sodium levels due to ACE‑inhibitor effects. - History of angioedema: avoid in individuals with prior ACE‑inhibitor–related swelling. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at ambient temperature: keep tablets in the original container, protect from moisture and direct sunlight.

Icomb may interact with several medicines; careful review is advised. Major Interactions (Avoid): - Concomitant ACE inhibitor, ARB, or aliskiren: risk of excessive renin‑angiotensin blockade and hyperkalemia. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase amlodipine plasma levels, raising hypotension risk. - Simvastatin >20 mg: elevated statin concentrations may cause myopathy.

Moderate Interactions (Monitor Closely): - Diuretics (thiazides, loop): may enhance blood‑pressure lowering and electrolyte shifts. - Lithium: possible increase in lithium levels, requiring serum monitoring. - NSAIDs: may blunt antihypertensive effect and affect renal function. - Grapefruit juice: can modestly raise amlodipine concentrations. - Other antihypertensives: additive hypotensive effect, adjust dose as needed.